NIH Launches Collaborative Program with Industry and Researchers to Spur Therapeutic Development
May 22, 2012
The National Institutes of Health today unveiled a collaborative program that will match researchers with a selection of pharmaceutical industry compounds to help scientists explore new treatments for patients. NIH's new National Center for Advancing Translational Sciences (NCATS) has partnered initially with Pfizer, AstraZeneca, and Eli Lilly and Company which have agreed to make dozens of their compounds available for this initiative's pilot phase.
See more information on this news item.
From the National Center for Advancing Translational Sciences
From the National Institutes of Health